Integrating Engineering, Automation, and Intelligence to Catalyze the Biomedical Translation of Organoids.

Adv Biol (Weinh)

Tsinghua-Berkeley Shenzhen Institute (TBSI), Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen, 518055, China.

Published: August 2021

Organoid technology has developed at an impressive speed during the past decade. Still, organoids are not widely used in practical applications as expected. It is believed that this translation can be greatly accelerated with the integration of engineering and artificial intelligence into current research practices. It is proposed that this approach is the missing link to realize key milestones in organoid technology, namely, high-throughput, homogeneous, and standardized production, automated manipulation, and intelligent monitoring, evaluation, and control via integrated on-chip instrumentation and artificial intelligence. It is suggested that organoids-on-a-chip are the ideal platform to achieve these feats. Once these techniques are established and adopted by the scientific community, the rapid translation of organoids may be seen from laboratories to the clinics and pharmaceutical industry.

Download full-text PDF

Source
http://dx.doi.org/10.1002/adbi.202100535DOI Listing

Publication Analysis

Top Keywords

translation organoids
8
organoid technology
8
artificial intelligence
8
integrating engineering
4
engineering automation
4
automation intelligence
4
intelligence catalyze
4
catalyze biomedical
4
biomedical translation
4
organoids organoid
4

Similar Publications

The U.S. Developmental Origins of Health and Disease (DOHaD) meeting is an annual conference of primarily U.

View Article and Find Full Text PDF

Skeletal organoids.

Biomater Transl

November 2024

Organoid Research Center, Institute of Translational Medicine, Shanghai University, Shanghai, China.

The skeletal system, composed of bones, muscles, joints, ligaments, and tendons, serves as the foundation for maintaining human posture, mobility, and overall biomechanical functionality. However, with ageing, chronic overuse, and acute injuries, conditions such as osteoarthritis, intervertebral disc degeneration, muscle atrophy, and ligament or tendon tears have become increasingly prevalent and pose serious clinical challenges. These disorders not only result in pain, functional loss, and a marked reduction in patients' quality of life but also impose substantial social and economic burdens.

View Article and Find Full Text PDF

Organoids: the future of disease modelling and therapeutics.

Biomater Transl

November 2024

Organoid Research Center, Institute of Translational Medicine, Shanghai University, Shanghai, China.

View Article and Find Full Text PDF

Synthetic organ models such as organoids and organ-on-a-chip have been receiving recognition from administrative agencies. Despite the proven success of organoids in predicting drug efficacy on laboratory scales, their translational advances have not fully satisfied the expectations for both clinical implementation and commercial applications. The transition from laboratory settings to clinical applications continues to encounter challenges.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!